BMAA

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBMAA
Drug Alias NameBMAA
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSemaphorins inhibitors
TargetsSemaphorins
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChiome Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesChiome Bioscience Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A